Development of <i>neffy</i>, an Epinephrine Nasal Spray, for Severe Allergic Reactions
Epinephrine autoinjectors (EAIs) are used for the treatment of severe allergic reactions in a community setting; however, their utility is limited by low prescription fulfillment rates, failure to carry, and failure to use due to fear of needles. Given that delayed administration of epinephrine is a...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2024-06-01
|
| シリーズ: | Pharmaceutics |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/1999-4923/16/6/811 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
